MedTrace Logo

COVID-19 Patient Cohort: Retinal Damage in Non-invasive Retinal Imaging (OCTA)

NCT04881253 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 23

Last updated 2025-09-02

No results posted yet for this study

Summary

The objective of this research is to build a collection of non-invasive retinal imaging (OCT and OCTA) in order to investigate the incidence and impact of retinal damage in patients who have or have had COVID-19.

Conditions

  • Covid19
  • Retina Injury

Sponsors & Collaborators

  • Centre Hospitalier Intercommunal Creteil

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-11-05
Primary Completion
2023-01-17
Completion
2023-01-17

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04881253 on ClinicalTrials.gov